TITLE

Time to lift embryo research ban

PUB. DATE
November 1998
SOURCE
Nature;11/12/1998, Vol. 396 Issue 6707, p97
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Calls for a change in United States law regarding embryo research. Society's ability to regulate science; Advances in the culture of human embryonic stem cells; US ban on embryo research using federal funds; Lack of regulation for private sector; Geron, the company involved in embryo stem cell research; Need for further congressional debate on the matter.
ACCESSION #
1286757

 

Related Articles

  • Stem Cell Diversification. Hobson, Katherine // U.S. News & World Report;Aug2009, Vol. 146 Issue 7, p31 

    The article examines the decision of U.S. President Barack Obama to remove government policy that had restricted the use of embryonic stem cells in medical applications. While much progress has been made in the research of adult stem cells, embryonic cells still hold the most promise for...

  • Science policy and public accountability in Poland: the case of embryonic stem-cell research. Kulawik, Teresa // Science & Public Policy (SPP);Jul2009, Vol. 36 Issue 6, p468 

    This article examines how exercises of public involvement in science policy, which have been transported to the new member states via EU regulations, function in post-socialist democracies. Given Poland's agonistic and non-transparent policy style, the public consultation process in the case of...

  • Science and technology policy in brief.  // Issues in Science & Technology;Fall2011, Vol. 28 Issue 1, p30 

    The article presents news briefs related to U.S. science & technology policy. District Judge Royce Lamberth gave decision in favor conducting research on human embryonic stem cells. The House Natural Resources Subcommittee on Fisheries, Wildlife, Oceans and Insular Affairs examined the function...

  • ESC research cannot be ignored. Singh, Nandita // BioSpectrum;Jan2012, Vol. 10 Issue 1, p100 

    The author comments on the issues concerning embryonic stem cell (ESC) research in India. She highlights the decision of California-based Geron Corp. to exit in the market for ESC research to focus on other projects. She emphasizes the role of the government to impose policies to provide a clear...

  • Stem cell revival. Coghlan, Andy // New Scientist;10/27/2012, Vol. 216 Issue 2888, p4 

    The article reports on attempts to resume a human embryonic stem cells (hESCs) clinical trial program cancelled in 2011 by the biotechnology company Geron, noting that former Geron officials and the biotechnology firm BioTime have placed a bid for the stem cell assets of the original program.

  • "CIRM Awards $25 Mln To Support Spinal-Cord Injury Trial, $37.7 Mln for Basic Stem-Cell Science".  // Biomedical Market Newsletter;5/9/2011, p143 

    The article reports that the Governing Board of the California Institute for Regenerative Medicine (CIRM), the State Stem Cell Agency, has approved a grant worth 25 million dollars to support the first U.S. Food & Drug Administration (FDA)-approved clinical trial based on cells derived from...

  • 4 STEM CELL SCIENCE TAKES OFF. Heger, Monica // Discover;Jan/Feb2010, Vol. 31 Issue 1, p23 

    The article discusses the various U.S. stem cell studies being conducted since the ban on federal funding for stem cell research was overturned by U.S. President Barack Obama. Topics include an overview of the first clinical trial by the U.S. biotechnology company Geron using embryonic stem...

  • SCIENCE POLICY IN GOVERNMENT.  // Biologist;Jun2011, Vol. 58 Issue 2, p64 

    The article focuses on the need of the British government to embed science with the public policy development process. It notes that the ethical issues on gene therapy, embryonic stem cells and economic limitations on drug availability are examples of the medical-based applications of biology...

  • STEP FOR STEM CELLS. Park, Alice // Time;8/16/2010, Vol. 176 Issue 7, p15 

    The article reports that a human trial of an embryonic stem cell treatment for spinal cord injury has been approved by the U.S. Food and Drug Administration (FDA).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics